AO-022 is a potent conformational inhibitor of TALDO1. It reduces the protein expression of vimentin and snail, exhibiting antiproliferative and antitumor activities. AO-022 holds potential for use in breast cancer research.
Target:
Others
* VAT and and shipping costs not included. Errors and price changes excepted
